Free Trial
NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences logo
$3.19 -0.06 (-1.85%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$3.22 +0.02 (+0.78%)
As of 08:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Applied DNA Sciences Stock (NASDAQ:APDN)

Key Stats

Today's Range
$3.12
$3.25
50-Day Range
$3.19
$5.34
52-Week Range
$3.12
$1,976.25
Volume
49,352 shs
Average Volume
76,718 shs
Market Capitalization
$4.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Applied DNA Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

APDN MarketRank™: 

Applied DNA Sciences scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Applied DNA Sciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied DNA Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied DNA Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied DNA Sciences has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    13.66% of the float of Applied DNA Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied DNA Sciences has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied DNA Sciences has recently increased by 42.68%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Applied DNA Sciences does not currently pay a dividend.

  • Dividend Growth

    Applied DNA Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.66% of the float of Applied DNA Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied DNA Sciences has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied DNA Sciences has recently increased by 42.68%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Applied DNA Sciences has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Applied DNA Sciences this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    Only 3 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.03% of the stock of Applied DNA Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 22.22% of the stock of Applied DNA Sciences is held by institutions.

  • Read more about Applied DNA Sciences' insider trading history.
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APDN Stock News Headlines

Earnings Scheduled For August 26, 2025
Applied DNA Sciences Focuses on LineaRx for Growth
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
Applied DNA Sciences Regains Nasdaq Compliance
Applied DNA Sciences, Inc. (APDN) - Yahoo Finance
APDN - Applied DNA Sciences Inc News - Morningstar
See More Headlines

APDN Stock Analysis - Frequently Asked Questions

Applied DNA Sciences' stock was trading at $153.00 at the beginning of the year. Since then, APDN shares have decreased by 97.9% and is now trading at $3.19.

Applied DNA Sciences Inc (NASDAQ:APDN) released its earnings results on Thursday, August, 14th. The technology company reported ($34.00) earnings per share for the quarter, beating analysts' consensus estimates of ($37.50) by $3.50. The technology company earned $0.30 million during the quarter, compared to analyst estimates of $1.28 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 136.17% and a negative net margin of 399.91%.

Applied DNA Sciences shares reverse split before market open on Sunday, June 1st 2025.The 1-15 reverse split was announced on Sunday, June 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/14/2025
Today
8/29/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
PROTECTION - SFTY
Sub-Industry
Business Services
Current Symbol
NASDAQ:APDN
CIK
744452
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($923.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.99 million
Net Margins
-399.91%
Pretax Margin
-394.30%
Return on Equity
-136.17%
Return on Assets
-101.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.76
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$3.43 million
Price / Sales
1.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.41 per share
Price / Book
0.59

Miscellaneous

Outstanding Shares
1,290,000
Free Float
1,291,000
Market Cap
$4.12 million
Optionable
Optionable
Beta
-0.02

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:APDN) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners